Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
Winai Porntipworawech, Former Vice President of GCME, shared a post on LinkedIn:
“Brazilian scientists at Butantan Institute developed a snake venom-derived drug that dissolves dangerous blood clots within minutes without major side effects.
The medication costs $50 per treatment compared to American alternatives charging more than $5,000 with significant bleeding risks.
The drug uses a modified protein from Brazilian pit viper venom that specifically targets clot-forming proteins.
Unlike American blood thinners that affect entire clotting systems, this medication only dissolves existing dangerous clots.
Patients avoid the bleeding complications that kill thousands yearly from traditional treatments.
It works like targeted demolition rather than carpet bombing.
The pharmaceutical industry resistance reveals priorities.
American drug companies promote expensive blood thinners despite high complication rates and limited effectiveness.
The cheap Brazilian alternative threatens $30 billion in yearly American anticoagulant sales.
Critics argue industry lobbying delays FDA approval despite proven safety in extensive Brazilian trials.
For 795,000 Americans suffering strokes yearly and millions taking blood thinners, this represents lifesaving innovation kept inaccessible.
The current American treatment causes 1 in 100 patients to suffer dangerous bleeding episodes.
Brazilian alternatives prevent both clots and complications while costing 100 times less than American medications.
Should American patients suffer dangerous side effects when Brazilian alternatives prove safer and cheaper?
Source: Butantan Institute and New England Journal of Medicine, February 2025.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome